3 Oct 2025

Impact of Hyperthermia on Quality of Life (QoL): Pain Relief, Fatigue Reduction, and Adjuvant Immunological Benefits

Authority and Expertise (EEAT): By Dr. Veronica Iatan , MD, and Cristian Gologan M.Sc , Andromedichyperthermia Impact of Hyperthermia on Quality of Life (QoL): Pain Relief, Fatigue Reduction, and Adjuvant Immunological Benefits In modern oncology, cancer management aims for the optimal balance between Survival (OS/DFS) and *Quality of Life (QoL)*. Hyperthermia (HT) represents a unique…

Read More
3 Oct 2025

Hyperthermia and Survival of Cancer Patients: Clinical Evidence Demonstrating an Increase in Overall Survival (OS) by Over 50%

Authority and Expertise (EEAT): By Dr. Veronica Iatan , MD, and Cristian Gologan M.Sc , Andromedichyperthermia Hyperthermia and Survival of Oncology Patients: Clinical Evidence Demonstrating an Increase in Overall Survival (OS) in some cases by Over 50% In the fight against cancer, the ultimate goal is to prolong Overall Survival (OS) with minimal or no…

Read More
2 Oct 2025

Therapeutic Integration of Hyperthermia in Modern Oncology: A Critical Analysis of Phase III Trials and Meta-Analyses (OS, DFS, CR Endpoints)

Authority and Expertise (E-E-A-T): By Dr. Veronica Iatan, MD, and Cristian Gologan M.Sc., Andromedichyperthermia Therapeutic Integration of Hyperthermia in Modern Oncology: A Critical Analysis of Phase III Trials and Meta-Analyses (OS, DFS, CR Endpoints) 1. Executive Summary and Fundamental Principles of Hyperthermia (HT) Oncologic Hyperthermia (HT), defined as the controlled application of heat at temperatures…

Read More
Quasi feasibility study(case control) asscoaiting deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response
12 Aug 2017

Quasi feasibility study(case control) associating deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO

Quasi-Feasibility Clinical Trial: Deep Local Hyperthermia with HyDeep 600 WM mHT device & Standard Cancer Treatments ESHO 2014 Congress Poster: Andromedic Oncological Hyperthermia Device Clinical Study Quasi feasibility study (case-control) associating deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments.   Introduction This is the first clinical trial combining deep local hyperthermia with standard…

Read More
Preliminary results of chemoradiation plus hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma header
12 Aug 2017

Preliminary results of chemoradiation plus hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma ESHO

Clinical Trial: Preliminary Results of Chemoradiation plus Modulated RF-Hyperthermia and HDR Brachytherapy for LACC Presented at the European Society for Hyperthermic Oncology (ESHO) Congress Sapienza University Pilot Study: HyDeep 600WM efficacy in Locally Advanced Cervical Carcinoma (LACC).   Authors: E. Clarke, V. De Sanctis, C. Scaringi, M. Valeriani, M. F. Osti, R. Maurizi Enrici Sant’Andrea…

Read More
Deep regional hyperthermia in combination with whole brain radiotherapy (WBRT) in poor prognosis patients with Brain Metastases header
12 Aug 2017

Deep regional hyperthermia in combination with whole brain radiotherapy (WBRT) in poor prognosis patients with Brain Metastases

Deep locoregional Hyperthermia in Combination with Whole Brain Radiotherapy (WBRT) in Poor Prognosis Patients with Brain Metastases Clinical Trial Results: Efficacy of the HyDeep 600WM Hyperthermia Device Deep local hyperthermia (mHT) combined with WBRT in patients with poor prognosis brain metastases.   Clinical Trial Abstract Purpose: The aim of this clinical trial is to assess…

Read More